Aluminum-Adsorbed Vaccines and Chronic Diseases of the Medical Establishment
Few issues of contemporary science are more contentious than the relation between childhood vaccines and adverse health outcomes. So, whenever a new study appears, it attracts a lot of attention. See the new study by Andersson et al., titled Aluminum-adsorbed vaccines and chronic diseases in childhood. A nationwide cohort study appeared in the Annals of […]
Study on Aluminum Vaccine Adjuvants Not All It’s Cracked Up to Be
On July 15, 2025, a study conducted in Denmark was published in the journal Annals of Internal Medicine that concluded there is no evidence of a link between the aluminum vaccine adjuvant in and a wide range of chronic health conditions, including asthma, autism, and autoimmune diseases. The cohort study looked at data from 1,224,176 […]
COVID Antiviral Paxlovid Provides “No Significant Benefit” to Vaccinated Seniors
Paxlovid, the antiviral drug that became the go-to treatment for SARS-CoV-2 infections during the pandemic, did not reduce hospitalizations or death in older adults who had gotten COVID-19 shots, according to a new study published in the Journal of the American Medical Association (JAMA) last month. Researchers who tested the COVID treatment Paxlovid (nirmatrelvir-ritonavir) on […]
Low-Dose Aspirin Use Linked to Increased Internal Bleeding
A new survey published on June 25, 2024 in the Annals of Internal Medicine has found that tens of millions of adults aged 60 and older are unknowingly putting themselves at increased risk for internal bleeding by routinely taking low-dose aspirin. The survey results suggest that the drug’s potential risks may outweigh the drug’s potential […]
One in Five Paxlovid Users Experience COVID Rebound Infections
A new study published earlier this month suggests that people who took Pfizer’s Paxlovid (nirmatrelvir-ritonavir)—an antiviral drug treatment for COVID-19—are much more likely to experience reinfection than those who did not take the drug. The study, published in the Annals of Internal Medicine, reported that one in five people who take Paxlovid could experience rebound […]
CDC Recommends Four COVID-19 Shots for Immunocompromised People
On Oct. 25, 2021, the U.S. Centers for Disease Control and Prevention (CDC) updated its COVID-19 vaccine guidance for moderately to severely immunocompromised people over the age of 18 years to include a total of four doses of a COVID-19 biologic.1 Moderate to Severely Immune Compromised People Can Get A Fourth COVID Shot Six Months […]